RESOURCES
Items 133-142 of 142 Results
-
GMP-grade cell culture - expert interview
Our Material Compliance Manager, Maximilian Gert-Kleint discusses GMP-grade cell culture media and its importance in cell therapy research.
White Papers
-
In vitro angiogenesis advancements - expert interview
In this RegMedNet interview, our expert Dr. Iris Bischoff-Kont discusses recent advancements in angiogenesis research and its potential in regenerative medicine.
White Papers
-
Tumor organoids - expert interview
Tumor organoids are redefining cancer research. Our experts join BioTechniques to discuss future trends in cancer biology and personalized medicine.
White Papers
-
Understanding angiogenesis assays
Learn more about angiogenesis and four different in vitro assays in our infographic.
Posters
-
Cell cryopreservation in Cryo-SFM Plus
This application describes a detailed protocol for freezing and thawing cells using our advanced defined, animal component-free and protein-free Cryo-SFM Plus cryopreservation medium.
Application Notes
-
Revolutionizing regenerative medicine with ALI culture - expert interview
In this exclusive interview, Dr. Elfie Rödel discusses the transformative potential of the air-liquid interface (ALI) culture system in the field of regenerative medicine.
White Papers
-
Air-Liquid Interface for revolutionizing respiratory research
Discover how the Air-Liquid Interface (ALI) technique is transforming respiratory research.
Posters
-
Air-Liquid Interface Culture System for standardized respiratory research
Generation of a stable and functional 3D human airway model with primary human bronchial epithelial cells using the PromoCell Air-Liquid Interface Culture System.
Application Notes
-
Adoptive cell therapies: advancing cancer treatment for solid tumors
Discover the latest insights and strategies shaping the future of cancer treatment.
eBooks
-
Advancing immuno-oncology: Innovative solutions for adoptive cell therapy
Advances in immuno-oncology continue to transform cancer treatment, offering hope where traditional therapies have fallen short.
Application Notes